Synthesis of benzylated amine‐substituted xanthone derivatives and their antioxidant and anti‐inflammatory activities.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 1, p. 1, doi. 10.1002/ardp.202200418
- By:
- Publication type:
- Article
Works matching IS 03656233 AND DT 2023 AND VI 356 AND IP 1
Results: 16
1
2
New quinazolinone‐based derivatives as DHFR/EGFR‐TK inhibitors: Synthesis, molecular modeling simulations, and anticancer activity.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 1, p. 1, doi. 10.1002/ardp.202200417
- By:
- Publication type:
- Article
3
Pyrazolo[3,4‐d]pyrimidine scaffold: A review on synthetic approaches and EGFR and VEGFR inhibitory activities.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 1, p. 1, doi. 10.1002/ardp.202200424
- By:
- Publication type:
- Article
4
Editorial Board: Arch Pharm (1/2023).
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 1, p. 1, doi. 10.1002/ardp.202370002
- Publication type:
- Article
5
SAR exploration of the non‐imidazole histamine H<sub>3</sub> receptor ligand ZEL‐H16 reveals potent inverse agonism.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 1, p. 1, doi. 10.1002/ardp.202200451
- By:
- Publication type:
- Article
6
3‐[3‐(Phenalkylamino)cyclohexyl]phenols: Synthesis, biological activity, and in silico investigation of a naltrexone‐derived novel class of MOR‐antagonists.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 1, p. 1, doi. 10.1002/ardp.202200432
- By:
- Publication type:
- Article
7
Cover Picture: Arch Pharm (1/2023).
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 1, p. 1, doi. 10.1002/ardp.202370001
- Publication type:
- Article
8
Bioevaluation of synthetic pyridones as dual inhibitors of α‐amylase and α‐glucosidase enzymes and potential antioxidants.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 1, p. 1, doi. 10.1002/ardp.202200400
- By:
- Publication type:
- Article
9
Development of new Alzheimer's disease drug candidates using donepezil as a key model.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 1, p. 1, doi. 10.1002/ardp.202200398
- By:
- Publication type:
- Article
10
Benzenesulfonamides with trisubstituted triazole motif as selective carbonic anhydrase I, II, IV, and IX inhibitors.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 1, p. 1, doi. 10.1002/ardp.202200391
- By:
- Publication type:
- Article
11
Structure‐guided identification of a selective sulfonamide‐based inhibitor targeting the human carbonic anhydrase VA isoform.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 1, p. 1, doi. 10.1002/ardp.202200383
- By:
- Publication type:
- Article
12
BC‐11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS‐CoV‐2 host cell entry.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 1, p. 1, doi. 10.1002/ardp.202200371
- By:
- Publication type:
- Article
13
Synthesis and evaluation of novel xanthene‐based thiazoles as potential antidiabetic agents.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 1, p. 1, doi. 10.1002/ardp.202200356
- By:
- Publication type:
- Article
14
The synergy between nucleotide biosynthesis inhibitors and antiviral nucleosides: New opportunities against viral infections?
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 1, p. 1, doi. 10.1002/ardp.202200217
- By:
- Publication type:
- Article
15
1,3,4‐Thiadiazole and 1,2,4‐triazole‐5‐thione derivatives bearing 2‐pentyl‐5‐phenyl‐2,4‐dihydro‐3H‐1,2,4‐triazole‐3‐one ring: Synthesis, molecular docking, urease inhibition, and crystal structure
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 1, p. 1, doi. 10.1002/ardp.202200355
- By:
- Publication type:
- Article
16
Silver(I) pyridinyl complexes with benzothiazole, thiophene, and furan moieties: DNA/protein‐binding, antibacterial, antioxidant, and anticancer studies.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 1, p. 1, doi. 10.1002/ardp.202200308
- By:
- Publication type:
- Article